Sharps Technology signs deal to acquire Nephron's InjectEZ syringe plant for $50M

Sharps Technology signed an asset purchase agreement to acquire Nephron Pharmaceuticals' InjectEZ specialty syringe manufacturing facility for $50 million, backed by a term sheet for up to $75 million in debt financing.

“$50 Million acquisition of InjectEZ strengthens manufacturing capacity and establishes Sharps' leading position in the specialized copolymer prefillable syringe system industry”globenewswire.com

• 1 source
• globenewswire.comSharps Technology Signs Asset Purchase Agreement to AcquireSep 26, 2023

Summarized from public sources; check the original articles before acting on it.